Pearman ME, Tanaka H. Dairy: A lower percent investment in the volatile hypertensive environment. World J Hypertens 2015; 5(3): 104-106 [DOI: 10.5494/wjh.v5.i3.104]
Corresponding Author of This Article
Hirofumi Tanaka, PhD, Cardiovascular Aging Research Laboratory, Department of Kinesiology and Health Education, University of Texas at Austin, 2109 San Jacinto. Blvd, D3700, Austin, TX 78712, United States. htanaka@austin.utexas.edu
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hypertens. Aug 23, 2015; 5(3): 104-106 Published online Aug 23, 2015. doi: 10.5494/wjh.v5.i3.104
Dairy: A lower percent investment in the volatile hypertensive environment
Miriam E Pearman, Hirofumi Tanaka
Miriam E Pearman, Hirofumi Tanaka, Cardiovascular Aging Research Laboratory, Department of Kinesiology and Health Education, University of Texas at Austin, Austin, TX 78712, United States
Author contributions: Pearman ME and Tanaka H wrote the paper.
Conflict-of-interest statement: There are no conflicts of interest to report.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Hirofumi Tanaka, PhD, Cardiovascular Aging Research Laboratory, Department of Kinesiology and Health Education, University of Texas at Austin, 2109 San Jacinto. Blvd, D3700, Austin, TX 78712, United States. htanaka@austin.utexas.edu
Telephone: +1-512-2324801 Fax: +1-512-4710946
Received: March 26, 2015 Peer-review started: March 28, 2015 First decision: May 13, 2015 Revised: June 1, 2015 Accepted: July 7, 2015 Article in press: July 8, 2015 Published online: August 23, 2015 Processing time: 155 Days and 14.3 Hours
Abstract
In cross-sectional and intervention studies, low-fat dairy has proven to be effective in lowering blood pressure in a hypertensive population. Contributing mechanisms include the angiotensin-converting enzyme-inhibiting effects of peptides and possible interplay between calcium and vitamin D. Easily added to the diet, low-fat dairy is an attractive addition to nutritional, lifestyle, and pharmacological interventions to treat hypertension.
Core tip: Low-fat dairy has shown to be effective in lowering blood pressure in a hypertensive population. Contributing mechanisms include the angiotensin-converting enzyme-inhibiting effects of peptides and possible interplay between calcium and vitamin D. Easily added to the diet, low-fat dairy is an attractive addition to nutritional, lifestyle, and pharmacological interventions to treat hypertension.
